ZA961051B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA961051B
ZA961051B ZA961051A ZA961051A ZA961051B ZA 961051 B ZA961051 B ZA 961051B ZA 961051 A ZA961051 A ZA 961051A ZA 961051 A ZA961051 A ZA 961051A ZA 961051 B ZA961051 B ZA 961051B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA961051A
Other languages
English (en)
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of ZA961051B publication Critical patent/ZA961051B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ZA961051A 1995-02-11 1996-02-09 Pharmaceutical composition ZA961051B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA961051B true ZA961051B (en) 1996-09-11

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961051A ZA961051B (en) 1995-02-11 1996-02-09 Pharmaceutical composition

Country Status (18)

Country Link
US (2) US5886018A (hu)
EP (1) EP0809514A1 (hu)
JP (1) JPH10513464A (hu)
KR (1) KR19980702109A (hu)
AU (1) AU707220B2 (hu)
BR (1) BR9607433A (hu)
CA (1) CA2212041A1 (hu)
CZ (1) CZ252897A3 (hu)
EA (1) EA000211B1 (hu)
FI (1) FI973280A0 (hu)
GB (1) GB9502695D0 (hu)
HU (1) HUP9702448A2 (hu)
IL (1) IL117098A0 (hu)
NO (1) NO973656L (hu)
NZ (1) NZ300937A (hu)
PL (1) PL321734A1 (hu)
WO (1) WO1996024376A1 (hu)
ZA (1) ZA961051B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
CZ2006427A3 (cs) 2003-12-29 2006-11-15 Sepracor Inc. Pyrrolové a pyrazolové inhibitory DAAO
AP2888A (en) 2005-02-01 2014-05-31 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenic and its pharmaceutically acceptable salts
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
RU2020100230A (ru) 2017-06-12 2021-07-13 Глитек Ллс. Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
KR0178469B1 (ko) * 1990-07-16 1999-03-20 메이나드 알. 존슨 흥분성 아미노산 길항제
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
FI973280A (fi) 1997-08-08
WO1996024376A1 (en) 1996-08-15
NO973656L (no) 1997-10-08
AU4622896A (en) 1996-08-27
EP0809514A1 (en) 1997-12-03
NZ300937A (en) 1999-02-25
NO973656D0 (no) 1997-08-08
IL117098A0 (en) 1996-06-18
FI973280A0 (fi) 1997-08-08
US6020359A (en) 2000-02-01
US5886018A (en) 1999-03-23
HUP9702448A2 (hu) 1999-10-28
MX9706044A (es) 1998-06-28
CA2212041A1 (en) 1996-08-15
AU707220B2 (en) 1999-07-08
EA000211B1 (ru) 1998-12-24
CZ252897A3 (cs) 1998-03-18
BR9607433A (pt) 1998-05-26
JPH10513464A (ja) 1998-12-22
GB9502695D0 (en) 1995-03-29
KR19980702109A (ko) 1998-07-15
EA199700095A1 (ru) 1998-02-26
PL321734A1 (en) 1997-12-22

Similar Documents

Publication Publication Date Title
HU9601698D0 (en) Pharmaceutical composition
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
ZA967827B (en) Pharmaceutical compositions
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
EG24294A (en) Pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
ZA961051B (en) Pharmaceutical composition
GB9525194D0 (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
ZA968616B (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
ZA95736B (en) Pharmaceutical composition
HUP9602732A2 (en) Pharmaceutical composition comprising lanperisone
GB9515207D0 (en) Pharmaceutical composition
GB9507038D0 (en) Pharmaceutical composition
ZA961735B (en) Pharmaceutical composition
GB9507037D0 (en) Pharmaceutical composition
ZA9510132B (en) Pharmaceutical composition
HU9903430D0 (en) Pharmaceutical composition
GB9505368D0 (en) Pharmaceutical composition
GB9515723D0 (en) Pharmaceutical composition